Risk factors for benign, borderline and invasive mucinous ovarian tumors: Epidemiological evidence of a neoplastic continuum?

被引:52
作者
Jordan, Susan J. [1 ]
Green, Adele C.
Whiteman, David C.
Webb, Penelope M.
机构
[1] PO Royal Brisbane Hosp, Queensland Inst Med Res, Canc & Populat Studies Grp, Brisbane, Qld 4029, Australia
[2] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia
基金
英国医学研究理事会;
关键词
mucinous ovarian cancer; benign turnout; borderline turnout; risk factor;
D O I
10.1016/j.ygyno.2007.06.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective. Some molecular and histological evidence suggests that mucinous epithelial ovarian cancers develop via a sequence from benign tumor through borderline tumor to invasive cancer. Such a sequence would predict some shared risk factors between the different tumor types. To investigate this, we examined risk factors for benign, borderline and invasive mucinous ovarian tumors. Methods. A population-based case-control study was conducted in Australia between 2002 and 2005. Women with benign (n=33), borderline (n=147) and invasive (n=43) mucinous tumors of the ovary and women from the general population (n=1487) completed comprehensive health and lifestyle questionnaires. Results. Although parity was inversely related to risk of benign, borderline and invasive tumors, increasing numbers of births did not further decrease risk of any of the tumor types. Hormonal contraceptives and breast-feeding were unrelated to risk. However, 20 or more pack-years of smoking was associated with a more than twofold increase in risk of all three tumor types (OR=2.7, 95% CI 1.6-4.4 for benign tumors; OR 2.7, 95% CI 1.7-4.4 for borderline tumors; and OR=2.1, 95% CI 0.9-5.0 for invasive cancers) compared to never smoking. Conclusions. Overall, the risk factors for mucinous cancers appear to differ from other subtypes of ovarian cancer. Furthermore, patterns of risk factors across benign, borderline and invasive mucinous ovarian tumors are generally consistent with an adenoma-to-carcinoma sequence as the developmental pathway for this subtype of ovarian cancer. Our findings also suggest the potential preventability of borderline and invasive mucinous ovarian cancer by smoking cessation and by surgical excision of identifiable precursor lesions. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:223 / 230
页数:8
相关论文
共 35 条
[1]  
*ABS AUSTR BUR STA, 2006, NAT HLTH SURV US GUI
[2]   Origins and molecular pathology of ovarian cancer [J].
Bell, DA .
MODERN PATHOLOGY, 2005, 18 :S19-S32
[3]  
Berger DH, 1999, CANCER, V85, P326, DOI 10.1002/(SICI)1097-0142(19990115)85:2<326::AID-CNCR9>3.0.CO
[4]  
2-O
[5]  
Cuatrecasas M, 1997, CANCER, V79, P1581, DOI 10.1002/(SICI)1097-0142(19970415)79:8<1581::AID-CNCR21>3.0.CO
[6]  
2-T
[7]   Origin of ovarian cancer from benign cysts [J].
Dal Maso, L ;
Canzonieri, V ;
Talamini, R ;
Franceschi, S ;
La Vecchia, C .
EUROPEAN JOURNAL OF CANCER PREVENTION, 2001, 10 (02) :197-199
[8]  
FROST CA, 1994, BRIT J DERMATOL, V131, P455
[9]   k-ras mutation may be an early event in mucinous ovarian tumorigenesis [J].
Garrett, AP ;
Lee, KR ;
Colitti, CR ;
Muto, MG ;
Berkowitz, RS ;
Mok, SC .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2001, 20 (03) :244-251
[10]   Mucinous tumors of the ovary: A review [J].
Hart, WR .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2005, 24 (01) :4-25